| Discovery | Candidate | Preclinical | Phase I | Partner | |
|---|---|---|---|---|---|
|
DT-9081 - EP4 receptor antagonist
Solid Tumors + |
Phase I | ||||
|
M1069 - A2aR/A2bR antagonist
Solid Tumors + |
Phase I
|
||||
|
MC4 small molecule pharmacochaperone
Rare metabolic diseases + |
Discovery
|
||||
|
DT-7012 - Anti-CCR8 depleting antibody
Solid Tumors + |
Preclinical | ||||
|
DT-9046 - Biased antagonist of PAR2
Inflammation + |
Preclinical | ||||
|
Undisclosed GPCR targets
+ |
Discovery | ||||
|
DT-095435 - mGluR4/7/8 PAM
+ |
Candidate | ||||
|
NPFFR antagonist
+ |
Discovery | ||||
|
Multi-target collaboration for rare diseases
+ |
Discovery
|
||||
